Cost-Effectiveness of a Digitally Supported Care Management Program for Caregivers of People With Dementia

IF 6 2区 医学 Q1 ECONOMICS Value in Health Pub Date : 2025-04-01 Epub Date: 2025-02-06 DOI:10.1016/j.jval.2025.01.011
Michelle Pfaff MSc , Wolfgang Hoffmann MD, MPH , Melanie Boekholt MA , Olga Biernetzky PhD , Iris Blotenberg PhD , Dilshad Afrin MSc , Moritz Platen PhD , Stefan Teipel MD , Jochen René Thyrian PhD , Ingo Kilimann MD , Bernhard Michalowsky PhD
{"title":"Cost-Effectiveness of a Digitally Supported Care Management Program for Caregivers of People With Dementia","authors":"Michelle Pfaff MSc ,&nbsp;Wolfgang Hoffmann MD, MPH ,&nbsp;Melanie Boekholt MA ,&nbsp;Olga Biernetzky PhD ,&nbsp;Iris Blotenberg PhD ,&nbsp;Dilshad Afrin MSc ,&nbsp;Moritz Platen PhD ,&nbsp;Stefan Teipel MD ,&nbsp;Jochen René Thyrian PhD ,&nbsp;Ingo Kilimann MD ,&nbsp;Bernhard Michalowsky PhD","doi":"10.1016/j.jval.2025.01.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To examine the cost-effectiveness of a digitally supported care management system (CMS) for caregivers of people with dementia (PwD) compared with usual care.</div></div><div><h3>Methods</h3><div>The analysis was based on 192 caregivers (<em>n</em> = 96 CMS, <em>n</em> = 96 usual care) of PwD in a cluster-randomized controlled trial testing a digitally supported CMS, aiming to identify and address caregivers’ unmet needs and develop and implement an individualized support and care plan over 6 months. Incremental costs from the public-payer and societal perspectives, quality-adjusted life years (QALY), and the incremental cost-effectiveness ratio 6 months after baseline were calculated using multivariate regression models. We assessed the probability of cost-effectiveness using a range of willingness-to-pay thresholds.</div></div><div><h3>Results</h3><div>Caregivers in the intervention group gained QALYs (+0.004 [95% CI −0.003 to 0.012], <em>P</em> value = .225) and had lower costs from the public payer (−378€ [1926-1168], <em>P</em> value = .630), but higher costs from the societal perspective (+1324 [−3634 to 6284], <em>P</em> value = .599). The intervention dominated usual care from the payer perspective, whereas the incremental cost-effectiveness ratio was €331 000/QALY from a societal perspective. The probability of cost-effectiveness was 72% and 79% from the public payer and 33% and 35% from a societal perspective at the willingness-to-pay thresholds threshold of €40 000 and €80 000/QALY gained.</div></div><div><h3>Conclusions</h3><div>CMS was likely cost-effective from the payer but not from a societal perspective, underlining the importance of informal care. The gain in QALY was marginal and could be due to the short observation period. Focusing on both the caregiver and the PwD, rather than assessing the PwD needs through the caregiver, could improve the cost-effectiveness results.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"28 4","pages":"Pages 527-535"},"PeriodicalIF":6.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Value in Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1098301525000385","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

To examine the cost-effectiveness of a digitally supported care management system (CMS) for caregivers of people with dementia (PwD) compared with usual care.

Methods

The analysis was based on 192 caregivers (n = 96 CMS, n = 96 usual care) of PwD in a cluster-randomized controlled trial testing a digitally supported CMS, aiming to identify and address caregivers’ unmet needs and develop and implement an individualized support and care plan over 6 months. Incremental costs from the public-payer and societal perspectives, quality-adjusted life years (QALY), and the incremental cost-effectiveness ratio 6 months after baseline were calculated using multivariate regression models. We assessed the probability of cost-effectiveness using a range of willingness-to-pay thresholds.

Results

Caregivers in the intervention group gained QALYs (+0.004 [95% CI −0.003 to 0.012], P value = .225) and had lower costs from the public payer (−378€ [1926-1168], P value = .630), but higher costs from the societal perspective (+1324 [−3634 to 6284], P value = .599). The intervention dominated usual care from the payer perspective, whereas the incremental cost-effectiveness ratio was €331 000/QALY from a societal perspective. The probability of cost-effectiveness was 72% and 79% from the public payer and 33% and 35% from a societal perspective at the willingness-to-pay thresholds threshold of €40 000 and €80 000/QALY gained.

Conclusions

CMS was likely cost-effective from the payer but not from a societal perspective, underlining the importance of informal care. The gain in QALY was marginal and could be due to the short observation period. Focusing on both the caregiver and the PwD, rather than assessing the PwD needs through the caregiver, could improve the cost-effectiveness results.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
痴呆症患者护理人员数字化支持护理管理项目的成本效益。
目的:与常规护理相比,研究数字支持的痴呆症患者护理管理系统(CMS)的成本效益。方法:对192名PwD护理人员(n=96 CMS, n=96常规护理人员)进行聚类随机对照试验,测试数字支持CMS,旨在识别和解决护理人员未满足的需求,并制定和实施个性化的支持和护理计划6个月。采用多元回归模型计算公共支付者和社会角度的增量成本、质量调整生命年(QALY)和基线后6个月的增量成本-效果比(ICER)。我们使用一系列支付意愿阈值(WTP)来评估成本效益的可能性。结果:干预组护理人员获得了QALYs (+0.004 [CI95%-0.003-0.012], p值= 0.225),从公共支付者角度的成本较低(-378€[1,926-1,168],p值= 0.630),但从社会角度的成本较高(+1,324 [-3,634-6,284],p值= 0.599)。从付款人的角度来看,干预措施主导了常规护理,而从社会角度来看,ICER为33.1万欧元/QALY。从公共支付者的角度来看,成本效益的概率分别为72%和79%,从社会角度来看,在WTP门槛为40,000欧元和80,000欧元/QALY时,成本效益的概率分别为33%和35%。讨论:从付款人的角度来看,CMS可能具有成本效益,但从社会的角度来看,却不是这样,强调了非正式护理的重要性。QALY的增加是边际的,可能是由于观察期短。同时关注护理者和残疾人士,而不是通过护理者来评估残疾人士的需求,可以提高成本效益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Value in Health
Value in Health 医学-卫生保健
CiteScore
6.90
自引率
6.70%
发文量
3064
审稿时长
3-8 weeks
期刊介绍: Value in Health contains original research articles for pharmacoeconomics, health economics, and outcomes research (clinical, economic, and patient-reported outcomes/preference-based research), as well as conceptual and health policy articles that provide valuable information for health care decision-makers as well as the research community. As the official journal of ISPOR, Value in Health provides a forum for researchers, as well as health care decision-makers to translate outcomes research into health care decisions.
期刊最新文献
Switching from EQ-5D-3L to EQ-5D-5L in England: the impact in NICE technology appraisals. Integrating Generative AI Into Evidence Synthesis: Opportunities, Safeguards, and Methodological Refinements. A UK value set for the EQ-5D-5L. Real-World Evidence in the First Round of the US Inflation Reduction Act Drug Price Negotiations: A Citation Analysis of CMS Maximum Fair Price Explanation Documents. Fast Science, Slow Evaluation: What Makes Health Technology Assessment of Genetic and Genomic Technologies So Complicated? A Systematic Review of Methodological Challenges and Identified Suggestions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1